Chinese BioPharma Co. Lands $86.73M Private Placement
China-based biopharmaceutical company Sinovac Biotech Ltd. said on Tuesday that it has received $86.73 million from a private placement of its common shares with private equity funds Vivo Capital and Advantech...To view the full article, register now.
Already a subscriber? Click here to view full article